Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Vascular Embolization Market Analysis

ID: MRFR/HC/10351-HCR
128 Pages
Kinjoll Dey
December 2024

Vascular Embolization Market Size, Growth Research Report By Embolization Technique (Coiling Devices and Non-coiling Devices), By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, and Other), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Competitor Industry Analysis and Trends Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Vascular Embolization Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Analysis

In-depth Analysis of Vascular Embolization Market Industry Landscape

The global vascular embolization market is set to reach US$ 4.0 BN by 2032, at a 9.90% CAGR between years 2023-2032. The vascular embolization market works on an environment which is highly dynamic in nature, where various elements are propelling the requirement of newer innovations and devices that fall under this category. An important factor is growing incidence of vascular disorders and diseases as aneurisms or arteriovenous malformations. As the prevalence of these conditions increases around the world, so does demand to respond effectively with embolization solutions that shape market dynamics in response to this growing need. The market dynamics are greatly influenced by the technological advances in embolization devices. The constant innovations in materials, design, and delivery systems further lead to better embolization techniques with increasing precision and minimally invasive nature. The market competitively responds to such technological advances by providing a series of high-quality devices which help improve patient safety, efficiency, and versatility in vascular embolization procedures. Regulatory issues and compliance standards are among the major drivers of market trends. Thus, patient safety and efficacy of new embolization devices are verified during the approval and clearance processes under highly regulated conditions. Strategies of market players are influenced by compliance with regulatory requirements, which also determines product development, clinical trials, and entry into the markets. Embolization devices gain credibility and trustworthiness in the healthcare environment with a well-developed regulatory framework. Market dynamics include economic factors such as healthcare spending and cost-effectiveness. The goal of healthcare providers in finding an embolization solution is to strike a balance between cost and quality. Depending on the cost-effectiveness of embolization procedures and devices, adoption of new technologies is dictated determining market trends while healthcare institutions seek to reduce wastages. The dynamics of the vascular embolization market are influenced by globalisation and growth in markets. Companies are increasing market penetration through strategic alliances, collaborations as well as distribution agreements which provide them with access to new geographic regions. This globalization creates a more interdependent market wherein the manufacturers customize their products to suit those need which vary in healthcare providers and patients all over the world. Aging population and the resulted increase in age-related vascular conditions have a great influence on market dynamics. As the population continues to get older, some of these conditions such as cerebral aneurysms and peripheral artery disease become prevalent. The market addresses this demographic trend by emphasizing the development of embolization devices suitable for older individuals, focusing on issues and aspects related to aging vascular structures.

Author
Author Profile
Kinjoll Dey
Senior Research Analyst

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

Leave a Comment

FAQs

What is the current valuation of the Vascular Embolization Market as of 2024?

<p>The Vascular Embolization Market was valued at 2.088 USD Billion in 2024.</p>

What is the projected market size for the Vascular Embolization Market in 2035?

<p>The market is projected to reach 5.9 USD Billion by 2035.</p>

What is the expected CAGR for the Vascular Embolization Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the market during 2025 - 2035 is 9.9%.</p>

Which companies are considered key players in the Vascular Embolization Market?

<p>Key players include Medtronic, Boston Scientific, Terumo Corporation, and Johnson & Johnson, among others.</p>

What are the main segments of the Vascular Embolization Market?

<p>The main segments include Technique and Application, with specific categories like Coiling Devices and Oncology.</p>

How did the Coiling Devices segment perform in 2024?

<p>The Coiling Devices segment was valued at 0.835 USD Billion in 2024.</p>

What is the projected growth for Non-coiling Devices by 2035?

The Non-coiling Devices segment is expected to grow from 1.253 USD Billion in 2024 to 3.5 USD Billion by 2035.

Which application segment is anticipated to have the highest growth in the Vascular Embolization Market?

The Oncology application segment is projected to grow from 0.8 USD Billion in 2024 to 2.3 USD Billion by 2035.

What is the valuation of the Peripheral Vascular Disease segment in 2024?

The Peripheral Vascular Disease segment was valued at 0.5 USD Billion in 2024.

How does the growth of the Vascular Embolization Market compare to other medical device markets?

The Vascular Embolization Market's growth appears robust, with a projected CAGR of 9.9% during 2025 - 2035, indicating strong demand.

Market Summary

As per Market Research Future analysis, the Vascular Embolization Market was estimated at 2.088 USD Billion in 2024. The Vascular Embolization industry is projected to grow from 2.295 USD Billion in 2025 to 5.9 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 9.9% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Vascular Embolization Market is poised for substantial growth driven by technological advancements and increasing demand for minimally invasive procedures.

  • Technological advancements are enhancing the efficacy and safety of vascular embolization procedures. North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region in this sector. Coiling devices dominate the market, whereas non-coiling devices are witnessing rapid growth due to their innovative designs. Key market drivers include the rising prevalence of vascular disorders and a growing preference for minimally invasive techniques.

Market Size & Forecast

2024 Market Size 2.088 (USD Billion)
2035 Market Size 5.9 (USD Billion)
CAGR (2025 - 2035) 9.9%
Largest Regional Market Share in 2024 North America

Major Players

Medtronic (US), Boston Scientific (US), Terumo Corporation (JP), Johnson &amp; Johnson (US), Stryker Corporation (US), Cook Medical (US), B. Braun Melsungen AG (DE), Abbott Laboratories (US), AngioDynamics (US)

Market Trends

The Vascular Embolization Market is currently experiencing a notable transformation, driven by advancements in medical technology and an increasing prevalence of vascular diseases. As healthcare providers seek innovative solutions to manage conditions such as tumors and vascular malformations, the demand for embolization procedures is on the rise. This market appears to be influenced by a growing awareness of minimally invasive techniques, which offer patients reduced recovery times and lower risks compared to traditional surgical methods. Furthermore, the integration of advanced imaging technologies is enhancing the precision of these procedures, thereby improving patient outcomes and satisfaction. In addition, the Vascular Embolization Market is likely to benefit from ongoing research and development efforts aimed at creating new embolic agents and devices. These innovations may provide healthcare professionals with a broader range of options to tailor treatments to individual patient needs. Moreover, the increasing collaboration between medical device manufacturers and healthcare institutions suggests a trend towards more comprehensive care solutions. As the market evolves, it seems poised for sustained growth, reflecting the dynamic nature of the healthcare landscape and the continuous pursuit of improved therapeutic strategies.

Technological Advancements

The Vascular Embolization Market is witnessing a surge in technological innovations, particularly in the development of new embolic materials and delivery systems. These advancements are enhancing the efficacy and safety of embolization procedures, making them more appealing to both healthcare providers and patients.

Rising Incidence of Vascular Diseases

There is a growing prevalence of vascular diseases globally, which is driving the demand for embolization procedures. As more individuals are diagnosed with conditions requiring intervention, the Vascular Embolization Market is likely to expand to meet this increasing need.

Shift Towards Minimally Invasive Procedures

Healthcare professionals are increasingly favoring minimally invasive techniques over traditional surgical options. This shift is influencing the Vascular Embolization Market, as patients seek treatments that offer quicker recovery times and fewer complications.

Vascular Embolization Market Market Drivers

Increasing Prevalence of Vascular Disorders

The rising incidence of vascular disorders, such as arteriovenous malformations and uterine fibroids, is a significant driver for the Vascular Embolization Market. As populations age and lifestyle-related health issues become more common, the demand for effective treatment options is escalating. Recent statistics indicate that vascular diseases affect millions worldwide, leading to a heightened need for minimally invasive interventions. The Vascular Embolization Market is poised to benefit from this trend, as embolization procedures offer a less invasive alternative to traditional surgical methods. This shift not only improves patient recovery times but also reduces healthcare costs, further propelling market growth. The increasing awareness of vascular health and the importance of early intervention is likely to sustain this upward trajectory in the coming years.

Regulatory Support and Reimbursement Policies

Regulatory support and favorable reimbursement policies are pivotal factors influencing the Vascular Embolization Market. Governments and health authorities are increasingly recognizing the importance of embolization procedures in treating vascular conditions, leading to the establishment of supportive regulatory frameworks. Additionally, many insurance providers are expanding coverage for these minimally invasive treatments, which enhances patient access and encourages healthcare providers to adopt these techniques. The alignment of regulatory policies with clinical guidelines is likely to foster innovation and investment in the Vascular Embolization Market. As reimbursement models evolve to favor cost-effective and efficient treatments, the market is expected to experience sustained growth, driven by increased adoption of embolization procedures.

Rising Investment in Healthcare Infrastructure

Investment in healthcare infrastructure is a crucial driver for the Vascular Embolization Market. Governments and private entities are increasingly allocating resources to enhance medical facilities and expand access to advanced treatment options. This trend is particularly evident in emerging economies, where the establishment of specialized vascular centers is on the rise. Enhanced infrastructure not only facilitates the adoption of cutting-edge embolization technologies but also improves patient access to these services. As healthcare systems evolve, the Vascular Embolization Market is likely to benefit from increased patient volumes and a broader range of treatment offerings. The ongoing commitment to healthcare improvement suggests a promising outlook for the industry, with potential growth opportunities in various regions.

Technological Innovations in Vascular Embolization

The Vascular Embolization Market is experiencing a surge in technological innovations that enhance the efficacy and safety of procedures. Advanced imaging techniques, such as 3D angiography and real-time ultrasound, are becoming increasingly prevalent, allowing for more precise targeting of embolization agents. Furthermore, the development of novel embolic materials, including bioresorbable microspheres and liquid embolics, is expanding treatment options for clinicians. According to recent data, the market for embolization devices is projected to grow at a compound annual growth rate of approximately 6.5% over the next several years. This growth is indicative of the industry's response to the demand for improved patient outcomes and reduced procedural risks, thereby driving the overall expansion of the Vascular Embolization Market.

Growing Preference for Minimally Invasive Techniques

The Vascular Embolization Market is witnessing a marked shift towards minimally invasive techniques, which are favored by both patients and healthcare providers. These procedures typically result in shorter hospital stays, reduced pain, and quicker recovery times compared to conventional surgical approaches. As patients increasingly seek out options that minimize disruption to their daily lives, the demand for embolization procedures is expected to rise. Market analysis suggests that the minimally invasive segment is likely to capture a larger share of the overall vascular intervention market, with projections indicating a growth rate of around 7% annually. This trend reflects a broader movement within the healthcare sector towards patient-centered care, which is anticipated to further bolster the Vascular Embolization Market.

Market Segment Insights

By Technique: Coiling Devices (Largest) vs. Non-coiling Devices (Fastest-Growing)

In the Vascular Embolization Market, coiling devices hold the largest market share due to their established efficacy in treating intracranial aneurysms and vascular lesions. These devices have been widely accepted by healthcare professionals, leading to significant preference over non-coiling methods in numerous procedures. Meanwhile, non-coiling devices are gaining traction, particularly among physicians looking for innovative, less invasive options, but currently occupy a smaller share of the market. The growth trends in this segment are largely driven by advancements in technology and the increasing prevalence of vascular diseases. Coiling devices continue to benefit from ongoing innovations that enhance their effectiveness and ease of use. Conversely, non-coiling devices are emerging as a fast-growing segment, fueled by rising demand for innovative procedures that reduce recovery times and potential complications, indicating a shift in treatment paradigms within the industry.

Technique: Coiling Devices (Dominant) vs. Non-coiling Devices (Emerging)

Coiling devices are characterized by their established presence in the Vascular Embolization Market and are primarily used for the treatment of aneurysms. Their market dominance stems from years of clinical success and widespread acceptance among medical professionals, resulting in high utilization rates. In contrast, non-coiling devices, which include various catheter-based options and new technologies, represent an emerging category aimed at fulfilling unmet clinical needs. These devices are designed to offer alternative solutions that minimize patient risks and enhance procedural efficiency, thereby attracting increasing interest from physicians seeking innovative treatment modalities. As the medical landscape evolves, these non-coiling options are expected to see accelerated adoption, driven by ongoing research and development.

By Application: Peripheral Vascular Disease (Largest) vs. Oncology (Fastest-Growing)

The Vascular Embolization Market exhibits a diverse range of application segments, with Peripheral Vascular Disease commanding a significant share due to the rising incidence of vascular disorders globally. Oncology follows closely behind, where tumor embolization procedures are gaining traction, thereby expanding its footprint in the market. Other segments such as Neurology and Urology, though smaller in comparison, still hold importance due to specific therapeutic needs in embolization treatments, resulting in a well-rounded distribution across various clinical applications. Growth trends within this segment are heavily influenced by technological advancements and increasing clinical indications for embolization. The increasing prevalence of chronic diseases, coupled with the rise in minimally invasive procedures, propels the demand for vascular interventions. Oncology is particularly witnessing accelerated growth as innovations in targeted therapies and embolization techniques enhance treatment outcomes. Furthermore, collaborative efforts among healthcare stakeholders strengthen market penetration, ensuring a robust future landscape for these applications.

Peripheral Vascular Disease (Dominant) vs. Oncology (Emerging)

Peripheral Vascular Disease stands out as the dominant application in the Vascular Embolization Market, characterized by a high volume of procedures related to limb ischemia and arterial blockages. Its established protocols and efficacy in managing chronic conditions solidify its leading status. On the other hand, Oncology is emerging rapidly, driven by a growing recognition of the role of embolization in treating various tumors. The evolution of skilled interventional radiology and the incorporation of advanced embolic agents highlight its potential. While Peripheral Vascular Disease benefits from a traditional patient base, Oncology is garnering interest due to increased research and successful clinical outcomes, positioning it as a key player in the future market.

Get more detailed insights about Vascular Embolization Market Research Report—Global Forecast till 2035

Regional Insights

North America : Market Leader in Innovation

North America is the largest market for vascular embolization, holding approximately 45% of the global share. The region benefits from advanced healthcare infrastructure, high prevalence of vascular diseases, and significant investments in medical technology. Regulatory support from agencies like the FDA further drives innovation and adoption of new embolization techniques, enhancing market growth. The United States is the primary contributor, with key players such as Medtronic, Boston Scientific, and Johnson & Johnson leading the competitive landscape. The presence of established healthcare systems and a focus on minimally invasive procedures are pivotal in shaping market dynamics. The region's emphasis on research and development ensures a steady pipeline of innovative products, catering to the growing demand for effective vascular treatments.

Europe : Emerging Market with Growth Potential

Europe is witnessing significant growth in the vascular embolization market, accounting for approximately 30% of the global share. Factors such as an aging population, increasing awareness of vascular diseases, and supportive healthcare policies are driving demand. The European Medicines Agency (EMA) plays a crucial role in regulating and approving new embolization devices, fostering innovation in the sector. Leading countries include Germany, France, and the UK, where major players like B. Braun Melsungen AG and Terumo Corporation are actively involved. The competitive landscape is characterized by collaborations and partnerships aimed at enhancing product offerings. The region's focus on improving patient outcomes through advanced medical technologies is expected to further boost market growth in the coming years.

Asia-Pacific : Rapidly Growing Healthcare Sector

Asia-Pacific is emerging as a significant player in the vascular embolization market, holding around 20% of the global share. The region's growth is fueled by increasing healthcare expenditure, rising prevalence of chronic diseases, and a growing middle-class population. Government initiatives aimed at improving healthcare access and affordability are also contributing to market expansion. Countries like Japan, China, and India are at the forefront, with key players such as Terumo Corporation and Abbott Laboratories making substantial investments. The competitive landscape is evolving, with local manufacturers entering the market, enhancing competition. The region's focus on technological advancements and partnerships with global firms is expected to drive further growth in the vascular embolization sector.

Middle East and Africa : Untapped Market with Opportunities

The Middle East and Africa represent an untapped market for vascular embolization, accounting for approximately 5% of the global share. The region is characterized by a growing demand for advanced medical technologies, driven by increasing healthcare investments and a rising burden of vascular diseases. Regulatory bodies are gradually improving frameworks to facilitate the introduction of innovative embolization products. Countries like South Africa and the UAE are leading the way, with a focus on enhancing healthcare infrastructure. The competitive landscape is still developing, with opportunities for both local and international players. The presence of key companies like Cook Medical and AngioDynamics is expected to stimulate market growth, as they introduce new technologies tailored to regional needs.

Key Players and Competitive Insights

The Vascular Embolization Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of vascular diseases. Key players such as Medtronic (US), Boston Scientific (US), and Terumo Corporation (JP) are strategically positioned to leverage innovation and expand their market presence. Medtronic (US) focuses on enhancing its product portfolio through continuous research and development, while Boston Scientific (US) emphasizes strategic partnerships to bolster its market reach. Terumo Corporation (JP) is actively pursuing regional expansion, particularly in emerging markets, which collectively shapes a competitive environment that is both collaborative and competitive.The market structure appears moderately fragmented, with several players vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which is essential in maintaining competitive pricing. The influence of major players is significant, as their operational strategies often set industry standards and drive innovation across the sector.
In August Medtronic (US) announced the launch of a new embolization device designed for minimally invasive procedures. This strategic move is likely to enhance their competitive edge by addressing the growing demand for less invasive treatment options, thereby appealing to both healthcare providers and patients. The introduction of this device may also reinforce Medtronic's commitment to innovation in the vascular space, potentially increasing its market share.
In September Boston Scientific (US) entered into a partnership with a leading telehealth provider to integrate digital solutions into its embolization products. This collaboration is indicative of a broader trend towards digital transformation in healthcare, suggesting that Boston Scientific is positioning itself to capitalize on the growing demand for remote patient monitoring and telemedicine solutions. Such initiatives may enhance patient outcomes and streamline operational efficiencies.
In July Terumo Corporation (JP) expanded its manufacturing capabilities in Southeast Asia, aiming to meet the rising demand for vascular embolization products in the region. This strategic expansion not only reflects Terumo's commitment to regional growth but also highlights the importance of supply chain optimization in a competitive market. By localizing production, Terumo may reduce lead times and improve responsiveness to market needs, thereby strengthening its competitive position.
As of October the Vascular Embolization Market is witnessing trends such as increased digitalization, sustainability initiatives, and the integration of artificial intelligence in product development. Strategic alliances are becoming increasingly vital, as companies seek to enhance their technological capabilities and market reach. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, advanced technology, and reliable supply chains, indicating a shift in how companies will compete in the future.

Key Companies in the Vascular Embolization Market include

Industry Developments

  • Q2 2024: Boston Scientific Announces FDA Clearance of the EMBOLX™ Vascular Embolization Market System Boston Scientific received FDA clearance for its EMBOLX™ Vascular Embolization Market System, expanding its portfolio of minimally invasive solutions for the treatment of vascular conditions.
  • Q2 2024: Penumbra Launches New Embolization Microcatheter Platform in the United States Penumbra announced the commercial launch of its latest embolization microcatheter platform, designed to improve precision and safety in vascular embolization procedures.
  • Q2 2024: Terumo Receives CE Mark for New HydroCoil Embolization System Terumo Corporation received CE Mark approval for its HydroCoil Embolization System, enabling commercialization in the European Union for neurovascular and peripheral vascular embolization.
  • Q2 2024: Medtronic Announces Strategic Partnership with Siemens Healthineers to Advance Image-Guided Vascular Embolization Market Medtronic entered a strategic partnership with Siemens Healthineers to integrate advanced imaging technologies into Medtronic’s vascular embolization product line.
  • Q3 2024: Abbott Launches New Embolization Coil for Peripheral Vascular Disease Abbott Laboratories launched a new embolization coil specifically designed for the treatment of peripheral vascular disease, expanding its interventional product portfolio.
  • Q3 2024: Cook Medical Opens New Manufacturing Facility for Embolization Devices in Indiana Cook Medical inaugurated a new manufacturing facility in Indiana dedicated to the production of vascular embolization devices, aiming to meet growing global demand.
  • Q3 2024: Stryker Receives FDA Approval for Next-Generation Neurovascular Embolization Device Stryker Corporation received FDA approval for its next-generation neurovascular embolization device, designed to treat cerebral aneurysms with enhanced safety and efficacy.
  • Q4 2024: Merit Medical Systems Announces Acquisition of Embolization Technology Startup Merit Medical Systems acquired a startup specializing in novel embolization technologies, aiming to strengthen its position in the vascular intervention market.
  • Q4 2024: Cerenovus Launches New Liquid Embolic Agent for Neurovascular Applications Cerenovus, a Johnson & Johnson company, launched a new liquid embolic agent for neurovascular applications, targeting the treatment of arteriovenous malformations and aneurysms.
  • Q1 2025: Boston Scientific Expands Vascular Embolization Market Portfolio with Acquisition of European Device Maker Boston Scientific acquired a European vascular embolization device manufacturer, broadening its product offerings and strengthening its presence in the region.
  • Q1 2025: Penumbra Announces $100 Million Series D Funding to Accelerate Embolization Technology Development Penumbra raised $100 million in Series D funding to support research and development of next-generation vascular embolization technologies.
  • Q2 2025: Terumo Opens New R&D Center Focused on Vascular Embolization Market Innovations Terumo Corporation opened a new research and development center dedicated to advancing vascular embolization device technology and clinical applications.

Future Outlook

Vascular Embolization Market Future Outlook

The Vascular Embolization Market is projected to grow at a 9.9% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of vascular diseases, and rising healthcare expenditure.

New opportunities lie in:

  • <p>Development of biodegradable embolic agents for enhanced patient safety. Expansion of telemedicine platforms for remote embolization consultations. Investment in AI-driven imaging technologies for improved procedural accuracy.</p>

By 2035, the Vascular Embolization Market is expected to achieve substantial growth and innovation.

Market Segmentation

Vascular Embolization Market Technique Outlook

  • Coiling Devices
  • Non-coiling Devices

Vascular Embolization Market Application Outlook

  • Peripheral Vascular Disease
  • Oncology
  • Neurology
  • Urology
  • Other

Report Scope

MARKET SIZE 2024 2.088(USD Billion)
MARKET SIZE 2025 2.295(USD Billion)
MARKET SIZE 2035 5.9(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 9.9% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Medtronic (US), Boston Scientific (US), Terumo Corporation (JP), Johnson & Johnson (US), Stryker Corporation (US), Cook Medical (US), B. Braun Melsungen AG (DE), Abbott Laboratories (US), AngioDynamics (US)
Segments Covered Embolization Technique, Application, Region
Key Market Opportunities Advancements in biocompatible materials enhance efficacy in the Vascular Embolization Market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the vascular embolization market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Vascular Embolization Market as of 2024?

<p>The Vascular Embolization Market was valued at 2.088 USD Billion in 2024.</p>

What is the projected market size for the Vascular Embolization Market in 2035?

<p>The market is projected to reach 5.9 USD Billion by 2035.</p>

What is the expected CAGR for the Vascular Embolization Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the market during 2025 - 2035 is 9.9%.</p>

Which companies are considered key players in the Vascular Embolization Market?

<p>Key players include Medtronic, Boston Scientific, Terumo Corporation, and Johnson & Johnson, among others.</p>

What are the main segments of the Vascular Embolization Market?

<p>The main segments include Technique and Application, with specific categories like Coiling Devices and Oncology.</p>

How did the Coiling Devices segment perform in 2024?

<p>The Coiling Devices segment was valued at 0.835 USD Billion in 2024.</p>

What is the projected growth for Non-coiling Devices by 2035?

The Non-coiling Devices segment is expected to grow from 1.253 USD Billion in 2024 to 3.5 USD Billion by 2035.

Which application segment is anticipated to have the highest growth in the Vascular Embolization Market?

The Oncology application segment is projected to grow from 0.8 USD Billion in 2024 to 2.3 USD Billion by 2035.

What is the valuation of the Peripheral Vascular Disease segment in 2024?

The Peripheral Vascular Disease segment was valued at 0.5 USD Billion in 2024.

How does the growth of the Vascular Embolization Market compare to other medical device markets?

The Vascular Embolization Market's growth appears robust, with a projected CAGR of 9.9% during 2025 - 2035, indicating strong demand.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Technique (USD Billion)
    2. | | 4.1.1 Coiling Devices
    3. | | 4.1.2 Non-coiling Devices
    4. | 4.2 Healthcare, BY Application (USD Billion)
    5. | | 4.2.1 Peripheral Vascular Disease
    6. | | 4.2.2 Oncology
    7. | | 4.2.3 Neurology
    8. | | 4.2.4 Urology
    9. | | 4.2.5 Other
    10. | 4.3 Healthcare, BY Region (USD Billion)
    11. | | 4.3.1 North America
    12. | | | 4.3.1.1 US
    13. | | | 4.3.1.2 Canada
    14. | | 4.3.2 Europe
    15. | | | 4.3.2.1 Germany
    16. | | | 4.3.2.2 UK
    17. | | | 4.3.2.3 France
    18. | | | 4.3.2.4 Russia
    19. | | | 4.3.2.5 Italy
    20. | | | 4.3.2.6 Spain
    21. | | | 4.3.2.7 Rest of Europe
    22. | | 4.3.3 APAC
    23. | | | 4.3.3.1 China
    24. | | | 4.3.3.2 India
    25. | | | 4.3.3.3 Japan
    26. | | | 4.3.3.4 South Korea
    27. | | | 4.3.3.5 Malaysia
    28. | | | 4.3.3.6 Thailand
    29. | | | 4.3.3.7 Indonesia
    30. | | | 4.3.3.8 Rest of APAC
    31. | | 4.3.4 South America
    32. | | | 4.3.4.1 Brazil
    33. | | | 4.3.4.2 Mexico
    34. | | | 4.3.4.3 Argentina
    35. | | | 4.3.4.4 Rest of South America
    36. | | 4.3.5 MEA
    37. | | | 4.3.5.1 GCC Countries
    38. | | | 4.3.5.2 South Africa
    39. | | | 4.3.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Medtronic (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Boston Scientific (US)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Terumo Corporation (JP)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Johnson & Johnson (US)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Stryker Corporation (US)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Cook Medical (US)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 B. Braun Melsungen AG (DE)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Abbott Laboratories (US)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 AngioDynamics (US)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY TECHNIQUE
    4. | 6.4 US MARKET ANALYSIS BY APPLICATION
    5. | 6.5 CANADA MARKET ANALYSIS BY TECHNIQUE
    6. | 6.6 CANADA MARKET ANALYSIS BY APPLICATION
    7. | 6.7 EUROPE MARKET ANALYSIS
    8. | 6.8 GERMANY MARKET ANALYSIS BY TECHNIQUE
    9. | 6.9 GERMANY MARKET ANALYSIS BY APPLICATION
    10. | 6.10 UK MARKET ANALYSIS BY TECHNIQUE
    11. | 6.11 UK MARKET ANALYSIS BY APPLICATION
    12. | 6.12 FRANCE MARKET ANALYSIS BY TECHNIQUE
    13. | 6.13 FRANCE MARKET ANALYSIS BY APPLICATION
    14. | 6.14 RUSSIA MARKET ANALYSIS BY TECHNIQUE
    15. | 6.15 RUSSIA MARKET ANALYSIS BY APPLICATION
    16. | 6.16 ITALY MARKET ANALYSIS BY TECHNIQUE
    17. | 6.17 ITALY MARKET ANALYSIS BY APPLICATION
    18. | 6.18 SPAIN MARKET ANALYSIS BY TECHNIQUE
    19. | 6.19 SPAIN MARKET ANALYSIS BY APPLICATION
    20. | 6.20 REST OF EUROPE MARKET ANALYSIS BY TECHNIQUE
    21. | 6.21 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    22. | 6.22 APAC MARKET ANALYSIS
    23. | 6.23 CHINA MARKET ANALYSIS BY TECHNIQUE
    24. | 6.24 CHINA MARKET ANALYSIS BY APPLICATION
    25. | 6.25 INDIA MARKET ANALYSIS BY TECHNIQUE
    26. | 6.26 INDIA MARKET ANALYSIS BY APPLICATION
    27. | 6.27 JAPAN MARKET ANALYSIS BY TECHNIQUE
    28. | 6.28 JAPAN MARKET ANALYSIS BY APPLICATION
    29. | 6.29 SOUTH KOREA MARKET ANALYSIS BY TECHNIQUE
    30. | 6.30 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    31. | 6.31 MALAYSIA MARKET ANALYSIS BY TECHNIQUE
    32. | 6.32 MALAYSIA MARKET ANALYSIS BY APPLICATION
    33. | 6.33 THAILAND MARKET ANALYSIS BY TECHNIQUE
    34. | 6.34 THAILAND MARKET ANALYSIS BY APPLICATION
    35. | 6.35 INDONESIA MARKET ANALYSIS BY TECHNIQUE
    36. | 6.36 INDONESIA MARKET ANALYSIS BY APPLICATION
    37. | 6.37 REST OF APAC MARKET ANALYSIS BY TECHNIQUE
    38. | 6.38 REST OF APAC MARKET ANALYSIS BY APPLICATION
    39. | 6.39 SOUTH AMERICA MARKET ANALYSIS
    40. | 6.40 BRAZIL MARKET ANALYSIS BY TECHNIQUE
    41. | 6.41 BRAZIL MARKET ANALYSIS BY APPLICATION
    42. | 6.42 MEXICO MARKET ANALYSIS BY TECHNIQUE
    43. | 6.43 MEXICO MARKET ANALYSIS BY APPLICATION
    44. | 6.44 ARGENTINA MARKET ANALYSIS BY TECHNIQUE
    45. | 6.45 ARGENTINA MARKET ANALYSIS BY APPLICATION
    46. | 6.46 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNIQUE
    47. | 6.47 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    48. | 6.48 MEA MARKET ANALYSIS
    49. | 6.49 GCC COUNTRIES MARKET ANALYSIS BY TECHNIQUE
    50. | 6.50 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    51. | 6.51 SOUTH AFRICA MARKET ANALYSIS BY TECHNIQUE
    52. | 6.52 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    53. | 6.53 REST OF MEA MARKET ANALYSIS BY TECHNIQUE
    54. | 6.54 REST OF MEA MARKET ANALYSIS BY APPLICATION
    55. | 6.55 KEY BUYING CRITERIA OF HEALTHCARE
    56. | 6.56 RESEARCH PROCESS OF MRFR
    57. | 6.57 DRO ANALYSIS OF HEALTHCARE
    58. | 6.58 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    59. | 6.59 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    60. | 6.60 SUPPLY / VALUE CHAIN: HEALTHCARE
    61. | 6.61 HEALTHCARE, BY TECHNIQUE, 2024 (% SHARE)
    62. | 6.62 HEALTHCARE, BY TECHNIQUE, 2024 TO 2035 (USD Billion)
    63. | 6.63 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    64. | 6.64 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    65. | 6.65 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
    6. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    7. | | 7.3.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    8. | | 7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
    9. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    10. | | 7.4.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    11. | | 7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
    12. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    13. | | 7.5.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    14. | | 7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
    15. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    16. | | 7.6.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    17. | | 7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
    18. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    19. | | 7.7.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    20. | | 7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
    21. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    22. | | 7.8.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    23. | | 7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
    24. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    25. | | 7.9.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    26. | | 7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
    27. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    28. | | 7.10.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    29. | | 7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
    30. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    31. | | 7.11.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    32. | | 7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
    33. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.12.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    35. | | 7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
    36. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    37. | | 7.13.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    38. | | 7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
    39. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    40. | | 7.14.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    41. | | 7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
    42. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    43. | | 7.15.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    44. | | 7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
    45. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    46. | | 7.16.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    47. | | 7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
    48. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    49. | | 7.17.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    50. | | 7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
    51. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    52. | | 7.18.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    53. | | 7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
    54. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    55. | | 7.19.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    56. | | 7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
    57. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    58. | | 7.20.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    59. | | 7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
    60. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    61. | | 7.21.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    62. | | 7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
    63. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.22.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    65. | | 7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
    66. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    67. | | 7.23.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    68. | | 7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
    69. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    70. | | 7.24.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    71. | | 7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
    72. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    73. | | 7.25.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    74. | | 7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
    75. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    76. | | 7.26.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    77. | | 7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
    78. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    79. | | 7.27.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    80. | | 7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
    81. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    82. | | 7.28.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    83. | | 7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
    84. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    85. | | 7.29.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    86. | | 7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
    87. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    88. | | 7.30.1 BY TECHNIQUE, 2025-2035 (USD Billion)
    89. | | 7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
    90. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    91. | | 7.31.1
    92. | 7.32 ACQUISITION/PARTNERSHIP
    93. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Technique (USD Billion, 2025-2035)

  • Coiling Devices
  • Non-coiling Devices

Healthcare By Application (USD Billion, 2025-2035)

  • Peripheral Vascular Disease
  • Oncology
  • Neurology
  • Urology
  • Other
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓